Reng‐Hong Wu
Papers
1
Total Citations
2
H-Index
1
About
Dr. Reng-Hong Wu is a pioneering urologic surgeon whose work centers on advancing minimally invasive techniques for renal cancer treatment. His primary research focus is the refinement of robot-assisted partial nephrectomy (RAPN), particularly for complex, totally endophytic renal masses. Dr. Wu’s major contribution lies in integrating superselective transarterial indocyanine green (ICG)-lipiodol embolization with the retroperitoneal approach. This innovative technique, detailed in his 2024 landmark paper, allows for precise, real-time fluorescence-guided tumor identification and resection, dramatically improving surgical accuracy and preserving healthy kidney tissue. While his most cited work is recent, its impact is already evident, garnering attention for addressing one of urologic oncology’s most challenging scenarios. Dr. Wu’s pioneering efforts are establishing a new standard for nephron-sparing surgery, offering patients with deep-seated tumors a safer, more effective alternative to radical nephrectomy. His ongoing work promises to further expand the boundaries of what is achievable with robotic surgery.
Research Focus
Key Achievements
Top Papers
- 1